Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 14, 2014

View Archived Issues

Academic team divulges novel FimH inhibitors

VolitionRx enters into agreement with University of Oxford for endometriosis diagnostic

Radboud University Medical Center wins NuGEN award for sarcoma genomics research

Medgenics and CHOP collaborate on pediatric rare and orphan genetic diseases

Enterome and AbbVie establish microbiome collaboration in Crohn's disease

Glionova Therapeutics raises financing for clinical development of glioblastoma candidate

BioCardia to conduct phase III trial of autologous bone marrow cell therapy for heart failure

GenomeDx and Mayo Clinic collaborate on expanded use of prostate cancer test

FDA approves supplemental NDAs for Invega Sustenna

First-in-human results for GSK-2878175 in healthy volunteers and patients with HCV

Advaxis submits IND for phase I/II study of ADXS-HPV and MEDI-4736 for HPV-related cancers

Phase II study of masitinib in hepatocellular cancer recommended to continue by DSMB

Safety and pharmacokinetic results for first-in-class HBV core inhibitor NVR-3-778

Suppression of Bcl-xL in hepatocellular carcinoma cells by TPU-0014

Presage expands cancer research agreement with Takeda

Arrien Pharmaceuticals patent details novel dual ITK/JAK3 inhibitors

Innocrin Pharmaceuticals to participate in phase II trial of VT-464 in prostate cancer

New lead candidates for broad-spectrum antimalarial drugs presented

University of Queensland developing new vaccine technology for polio

Japanese researchers describes anti-NLRR-1 MAbs

Merck & Co. presents preliminary phase I results for recombinant dengue vaccine

Janssen licenses Geron's imetelstat

Quatsomes EGF formulation developed to treat diabetic foot ulcers

Clinical trials of favipiravir and brincidofovir planned in Ebola virus outbreak region

Mitsubishi Tanabe seeks Japanese approval of Radicut for ALS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...